Results of a phase I trial of a recombinant vaccinia virus that expresses carcinoembryonic antigen in patients with advanced colorectal cancer (Q40928916)

From Wikidata

Jump to navigation Jump to search

scientific article published on September 1996

Language	Label	Description	Also known as
English	Results of a phase I trial of a recombinant vaccinia virus that expresses carcinoembryonic antigen in patients with advanced colorectal cancer	scientific article published on September 1996

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Results of a phase I trial of a recombinant vaccinia virus that expresses carcinoembryonic antigen in patients with advanced colorectal cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

phase I clinical trial

0 references

colorectal cancer

1 reference

based on heuristic

inferred from title

object named as

vaccinia virus

1 reference

based on heuristic

inferred from title

author name string

D McAneny

1

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

C A Ryan

2

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

R M Beazley

3

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

H L Kaufman

4

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

publication date

1 September 1996

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Annals of Surgical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

495-500

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Monoclonal antibody against carcinoembryonic antigen (CEA) identifies two new forms of crossreacting antigens of molecular weight 90,000 and 160,000 in normal granulocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/8876893

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8876893

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer statistics, 1995.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8876893

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serological studies of mucosal disease virus in England and Wales

1 reference

https://pubmed.ncbi.nlm.nih.gov/8876893

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A recombinant vaccinia virus expressing human carcinoembryonic antigen (CEA)

1 reference

https://pubmed.ncbi.nlm.nih.gov/8876893

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vaccinia virus expression vectors

1 reference

https://pubmed.ncbi.nlm.nih.gov/8876893

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary structure of human carcinoembryonic antigen (CEA) deduced from cDNA sequence

1 reference

https://pubmed.ncbi.nlm.nih.gov/8876893

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunogenicity and safety of a recombinant vaccinia virus vaccine expressing the carcinoembryonic antigen gene in a nonhuman primate

1 reference

https://pubmed.ncbi.nlm.nih.gov/8876893

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospectively randomized trial of adjuvant active-specific immunotherapy for human colorectal cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8876893

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antitumor Activity and Immune Responses Induced by a Recombinant Carcinoembryonic Antigen-Vaccinia Virus Vaccine

1 reference

https://pubmed.ncbi.nlm.nih.gov/8876893

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Specific active immunotherapy in patients with adenocarcinoma of the colon utilizing tumor-associated antigens (TAA). A phase I clinical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/8876893

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF02305769

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40928916&oldid=2204101676"